Celldex Therapeutics (CLDX)

Add to Watchlists
Create an Alert
15.15 +0.28  +1.88% NASDAQ Oct 20, 8:00PM BATS Real time Currency in USD
View Full Chart
CLDX Price Chart
View All Events

CLDX Events

Date Type Description
09/08/2014 13:25 EDT Misc Morgan Stanley Healthcare Conference
08/06/2014 16:30 EDT Misc Celldex Therapeutics Inc 2Q2014 Earning Conference Call
08/06/2014 Earnings Celldex Therapeutics Inc 2Q2014 Earning Result
05/28/2014 Misc Annual General Meeting for Celldex Therapeutics Inc
05/01/2014 Earnings Celldex Therapeutics Inc 1Q2014 Earning Result
05/01/2014 Misc Celldex Therapeutics Inc 1Q2014 Earning Conference Call
03/03/2014 08:30 EST Misc Celldex Therapeutics, Inc. Q4 2013 Earnings Conference Call
03/03/2014 Earnings Celldex Therapeutics, Inc. Q4 2013 Earnings Results
11/08/2013 Earnings Celldex Reports Third Quarter 2013 Financial Results
11/07/2013 Misc Celldex Reports Third Quarter 2013 Financial Results Conference Call
View All Performance Charts

CLDX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Celldex Therapeutics is down 41.28% over the last year vs S&P 500 Total Return up 12.13%, ARIAD Pharmaceuticals up 117.2%, and Alexion Pharmaceuticals up 55.12%.

Get Quote for

PDF Report for CLDX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CLDX Pro Report PDF
Advertisement

Portfolio Strategies Featuring CLDX

Did Celldex Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CLDX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.celldex.com
  • IR Website: http://ir.celldex.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Celldex Therapeutics, Inc., is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

CLDX Excel Add-In Codes

  • Name: =YCI("CLDX","name")
  • Description: =YCI("CLDX","description")
  • Sector: =YCI("CLDX","sector")
  • Industry: =YCI("CLDX","industry")
  • Est. Current Fiscal Year End: =YCI("CLDX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.